{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T14:32:16Z","timestamp":1754145136444,"version":"3.41.2"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,16]]},"DOI":"10.7759\/cureus.88073","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T13:40:58Z","timestamp":1752673258000},"source":"Crossref","is-referenced-by-count":0,"title":["Correlation Between Athlete Status and Clinical Features of Polycystic Ovary Syndrome in Collegiate Females"],"prefix":"10.7759","author":[{"given":"Lauren","family":"Hibshman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madeleine","family":"Schlehr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catelyn","family":"Rueger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Quint","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Speelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(22)00163-2","article-title":"Polycystic ovary syndrome","volume":"10","author":"Joham AE","year":"2022","unstructured":"Joham AE, Norman RJ, Stener-Victorin E, et al.. Polycystic ovary syndrome. Lancet Diabetes Endocrinol. 2022, 10:668-80. 10.1016\/S2213-8587(22)00163-2","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004, 81:19-25. 10.1016\/j.fertnstert.2003.10.004","journal-title":"Fertil Steril"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-8-41","article-title":"Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan","volume":"8","author":"Teede H","year":"2010","unstructured":"Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med. 2010, 8:41. 10.1186\/1741-7015-8-41","journal-title":"BMC Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/MOP.0000000000000778","article-title":"The diagnosis and treatment of PCOS in adolescents: an update","volume":"31","author":"Witchel SF","year":"2019","unstructured":"Witchel SF, Burghard AC, Tao RH, Oberfield SE. The diagnosis and treatment of PCOS in adolescents: an update. Curr Opin Pediatr. 2019, 31:562-9. 10.1097\/MOP.0000000000000778","journal-title":"Curr Opin Pediatr"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-09-0398","article-title":"Correlates of increased lean muscle mass in women with polycystic ovary syndrome","volume":"161","author":"Carmina E","year":"2009","unstructured":"Carmina E, Guastella E, Longo RA, Rini GB, Lobo RA. Correlates of increased lean muscle mass in women with polycystic ovary syndrome. Eur J Endocrinol. 2009, 161:583-9. 10.1530\/EJE-09-0398","journal-title":"Eur J Endocrinol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2012.708802","article-title":"Increase in subcutaneous adipose tissue and fat free mass in women with polycystic ovary syndrome is related to impaired insulin sensitivity","volume":"29","author":"Aydogdu A","year":"2013","unstructured":"Aydogdu A, Tasci I, Kucukerdonmez O, et al.. Increase in subcutaneous adipose tissue and fat free mass in women with polycystic ovary syndrome is related to impaired insulin sensitivity. Gynecol Endocrinol. 2013, 29:152-5. 10.3109\/09513590.2012.708802","journal-title":"Gynecol Endocrinol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2014.982083","article-title":"Women with polycystic ovary syndrome have greater muscle strength irrespective of body composition","volume":"31","author":"Kogure GS","year":"2015","unstructured":"Kogure GS, Silva RC, Picchi Ramos FK, Miranda-Furtado CL, Lara LA, Ferriani RA, Dos Reis RM. Women with polycystic ovary syndrome have greater muscle strength irrespective of body composition. Gynecol Endocrinol. 2015, 31:237-42. 10.3109\/09513590.2014.982083","journal-title":"Gynecol Endocrinol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1519\/JSC.0000000000002714","article-title":"Hyperandrogenism enhances muscle strength after progressive resistance training, independent of body composition, in women with polycystic ovary syndrome","volume":"32","author":"Kogure GS","year":"2018","unstructured":"Kogure GS, Silva RC, Miranda-Furtado CL, et al.. Hyperandrogenism enhances muscle strength after progressive resistance training, independent of body composition, in women with polycystic ovary syndrome. J Strength Cond Res. 2018, 32:2642-51. 10.1519\/JSC.0000000000002714","journal-title":"J Strength Cond Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/s0029-7844(01)01450-8","article-title":"Relationship of androgens to muscle size and bone mineral density in women with polycystic ovary syndrome","volume":"98","author":"Douchi T","year":"2001","unstructured":"Douchi T, Oki T, Yamasaki H, Kuwahata R, Nakae M, Nagata Y. Relationship of androgens to muscle size and bone mineral density in women with polycystic ovary syndrome. Obstet Gynecol. 2001, 98:445-9. 10.1016\/s0029-7844(01)01450-8","journal-title":"Obstet Gynecol"},{"key":"ref10","unstructured":"Adult BMI categories. (2024). Accessed. July 16, 2025: https:\/\/www.cdc.gov\/bmi\/adult-calculator\/bmi-categories.html."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.735954","article-title":"Dietary modification for reproductive health in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"12","author":"Shang Y","year":"2021","unstructured":"Shang Y, Zhou H, He R, Lu W. Dietary modification for reproductive health in women with polycystic ovary syndrome: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2021, 12:735954. 10.3389\/fendo.2021.735954","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/jfmk5020035","article-title":"A systematic review of the effects of exercise on hormones in women with polycystic ovary syndrome","volume":"5","author":"Shele G","year":"2020","unstructured":"Shele G, Genkil J, Speelman D. A systematic review of the effects of exercise on hormones in women with polycystic ovary syndrome. J Funct Morphol Kinesiol. 2020, 5:35. 10.3390\/jfmk5020035","journal-title":"J Funct Morphol Kinesiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-3399","article-title":"Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione","volume":"99","author":"O'Reilly MW","year":"2014","unstructured":"O'Reilly MW, Taylor AE, Crabtree NJ, et al.. Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione. J Clin Endocrinol Metab. 2014, 99:1027-36. 10.1210\/jc.2013-3399","journal-title":"J Clin Endocrinol Metab"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.2.484","article-title":"A unique defect in the regulation of visceral fat cell lipolysis in the polycystic ovary syndrome as an early link to insulin resistance","volume":"51","author":"Ek I","year":"2002","unstructured":"Ek I, Arner P, Ryd\u00e9n M, Holm C, Th\u00f6rne A, Hoffstedt J, Wahrenberg H. A unique defect in the regulation of visceral fat cell lipolysis in the polycystic ovary syndrome as an early link to insulin resistance. Diabetes. 2002, 51:484-92. 10.2337\/diabetes.51.2.484","journal-title":"Diabetes"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/BF03401335","article-title":"Elevated serum androstenedione is associated with a more severe phenotype in women with polycystic ovary syndrome (PCOS)","volume":"13","author":"Georgopoulos NA","year":"2014","unstructured":"Georgopoulos NA, Papadakis E, Armeni AK, Katsikis I, Roupas ND, Panidis D. Elevated serum androstenedione is associated with a more severe phenotype in women with polycystic ovary syndrome (PCOS). Hormones (Athens). 2014, 13:213-21. 10.1007\/BF03401335","journal-title":"Hormones (Athens)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2008.01.037","article-title":"Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria","volume":"198","author":"Kauffman RP","year":"2008","unstructured":"Kauffman RP, Baker TE, Baker VM, DiMarino P, Castracane VD. Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria. Am J Obstet Gynecol. 2008, 198:670.e1-7; discussion 670.e7-10. 10.1016\/j.ajog.2008.01.037","journal-title":"Am J Obstet Gynecol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1055\/s-2000-8847","article-title":"Exercise and insulin sensitivity: a review","volume":"21","author":"Borghouts LB","year":"2000","unstructured":"Borghouts LB, Keizer HA. Exercise and insulin sensitivity: a review. Int J Sports Med. 2000, 21:1-12. 10.1055\/s-2000-8847","journal-title":"Int J Sports Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(16)60060-2","article-title":"The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism","volume":"50","author":"Barbieri RL","year":"1988","unstructured":"Barbieri RL, Smith S, Ryan KJ. The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism. Fertil Steril. 1988, 50:197-212. 10.1016\/s0015-0282(16)60060-2","journal-title":"Fertil Steril"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/s0889-8529(05)70074-8","article-title":"Insulin action in the normal and polycystic ovary","volume":"28","author":"Franks S","year":"1999","unstructured":"Franks S, Gilling-Smith C, Watson H, Willis D. Insulin action in the normal and polycystic ovary. Endocrinol Metab Clin North Am. 1999, 28:361-78. 10.1016\/s0889-8529(05)70074-8","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi MO","year":"2011","unstructured":"Goodarzi MO, Dumesic DA, Chazenbalk G, Azziz R. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011, 7:219-31. 10.1038\/nrendo.2010.217","journal-title":"Nat Rev Endocrinol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmac023","article-title":"Comparison of dietary and physical activity behaviors in women with and without polycystic ovary syndrome: a systematic review and meta-analysis of 39\u200a471 women","volume":"28","author":"Kazemi M","year":"2022","unstructured":"Kazemi M, Kim JY, Wan C, et al.. Comparison of dietary and physical activity behaviors in women with and without polycystic ovary syndrome: a systematic review and meta-analysis of 39\u200a471 women. Hum Reprod Update. 2022, 28:910-55. 10.1093\/humupd\/dmac023","journal-title":"Hum Reprod Update"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10163469","article-title":"Dietary and physical activity habits in adolescent girls with polycystic ovary syndrome (PCOS)-HAstudy","volume":"10","author":"Mizgier M","year":"2021","unstructured":"Mizgier M, Jarz\u0105bek-Bielecka G, Formanowicz D, et al.. Dietary and physical activity habits in adolescent girls with polycystic ovary syndrome (PCOS)-HAstudy. J Clin Med. 2021, 10:3469. 10.3390\/jcm10163469","journal-title":"J Clin Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgae446","article-title":"Causal association between BMI and polycystic ovarian syndrome: bidirectional 2-sample Mendelian randomization study","volume":"110","author":"Fang Y","year":"2024","unstructured":"Fang Y, Liu L, Yang Y, Zhang B, Xie S. Causal association between BMI and polycystic ovarian syndrome: bidirectional 2-sample Mendelian randomization study. J Clin Endocrinol Metab. 2024, 110:41-7. 10.1210\/clinem\/dgae446","journal-title":"J Clin Endocrinol Metab"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dead053","article-title":"Childhood, adolescent, and adulthood adiposity are associated with risk of PCOS: a Mendelian randomization study with meta-analysis","volume":"38","author":"Dobbie LJ","year":"2023","unstructured":"Dobbie LJ, Pittam B, Zhao SS, Alam U, Hydes TJ, Barber TM, Cuthbertson DJ. Childhood, adolescent, and adulthood adiposity are associated with risk of PCOS: a Mendelian randomization study with meta-analysis. Hum Reprod. 2023, 38:1168-82. 10.1093\/humrep\/dead053","journal-title":"Hum Reprod"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0001013044.93371.7d","article-title":"Shortcomings of current PCOS care: provider bias and provider-patient goal misalignment [ID 2683466]","volume":"143","author":"Zhang A","year":"2024","unstructured":"Zhang A, McKenney K, Ross KV, Sehrt M, Ley SA, Phimphasone-Brady P. Shortcomings of current PCOS care: provider bias and provider-patient goal misalignment [ID 2683466]. Obstet Gynecol. 2024, 143:14S-5S. 10.1097\/01.AOG.0001013044.93371.7d","journal-title":"Obstet Gynecol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deab239","article-title":"Weight gain and lifestyle factors in women with and without polycystic ovary syndrome","volume":"37","author":"Awoke MA","year":"2021","unstructured":"Awoke MA, Earnest A, Joham AE, Hodge AM, Teede HJ, Brown WJ, Moran LJ. Weight gain and lifestyle factors in women with and without polycystic ovary syndrome. Hum Reprod. 2021, 37:129-41. 10.1093\/humrep\/deab239","journal-title":"Hum Reprod"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/nu15020295","article-title":"Emotional eating and binge eating disorders and night eating syndrome in polycystic ovary syndrome-a vicious circle of disease: a systematic review","volume":"15","author":"Burnatowska E","year":"2023","unstructured":"Burnatowska E, Wikarek A, Oboza P, Ogarek N, Glinianowicz M, Kocelak P, Olszanecka-Glinianowicz M. Emotional eating and binge eating disorders and night eating syndrome in polycystic ovary syndrome-a vicious circle of disease: a systematic review. Nutrients. 2023, 15:295. 10.3390\/nu15020295","journal-title":"Nutrients"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3390\/nu16071049","article-title":"Food cravings and obesity in women with polycystic ovary syndrome: pathophysiological and therapeutic considerations","volume":"16","author":"Stefanaki K","year":"2024","unstructured":"Stefanaki K, Karagiannakis DS, Peppa M, et al.. Food cravings and obesity in women with polycystic ovary syndrome: pathophysiological and therapeutic considerations. Nutrients. 2024, 16:1049. 10.3390\/nu16071049","journal-title":"Nutrients"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2375","article-title":"Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause","volume":"98","author":"Welt CK","year":"2013","unstructured":"Welt CK, Carmina E. Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause. J Clin Endocrinol Metab. 2013, 98:4629-38. 10.1210\/jc.2013-2375","journal-title":"J Clin Endocrinol Metab"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.23736\/S2724-6507.21.03349-6","article-title":"Polycystic ovary syndrome and obesity: clinical aspects and nutritional management","volume":"47","author":"Frias-Toral E","year":"2022","unstructured":"Frias-Toral E, Garcia-Velasquez E, de Los Angeles Carignano M, Rodriguez-Veintimilla D, Alvarado-Aguilera I, Bautista-Litardo N. Polycystic ovary syndrome and obesity: clinical aspects and nutritional management. Minerva Endocrinol (Torino). 2022, 47:215-41. 10.23736\/S2724-6507.21.03349-6","journal-title":"Minerva Endocrinol (Torino)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/372911-correlation-between-athlete-status-and-clinical-features-of-polycystic-ovary-syndrome-in-collegiate-females","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T13:40:59Z","timestamp":1752673259000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/372911-correlation-between-athlete-status-and-clinical-features-of-polycystic-ovary-syndrome-in-collegiate-females"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.88073","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,7,16]]}}}